Abstract
We provide evidence that the expression of the human MRP/GS-X pump encoded by the MRP (multidrug resistance associated protein) gene is induced by cisplatin in human leukemia HL-60/R-CP (cisplatin-resistant) cells and modulates cell growth inhibition by Δ7-prostaglandin A1 (PGA1) methyl ester. The MRP mRNA level in HL60/R-CP cells increased remarkably after a 24- h incubation with 20 μM cisplatin; interestingly, however, no amplification of the MRP gene was detected. In cisplatin-sensitive HL-60 cells, which express the MRP/GS-X pump at low levels, c-myc expression was substantially suppressed by Δ7-PGA1 methyl ester and the cell cycle was arrested in G1 phase. By contrast, in HL-60/R-CP cells overexpressing the MRP/GS-X pump, c- myc expression and cell proliferation were much less affected by Δ7-PGA1 methyl ester. This suggests that induction of the MRP/GS-X pump may confer on cancer cells resistance to anticancer prostaglandins and that the resistance mechanism may involve the increased efflux of PG-glutathione conjugates, as active intermediates, from the cells via the MRP/GS-X pump.
Original language | English (US) |
---|---|
Pages (from-to) | 221-227 |
Number of pages | 7 |
Journal | Cytotechnology |
Volume | 19 |
Issue number | 3 |
DOIs | |
State | Published - 1996 |
Keywords
- GS-X pump
- MRP
- anticancer prostaglandins
- cisplatin
- drug resistance
- glutathione
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biomedical Engineering
- Clinical Biochemistry
- Cell Biology